Altering Chemotherapy Improves Outcomes in Early-Stage Pancreatic Cancer

Results from two clinical trials are expected to improve the outlook for some people with early-stage pancreatic cancer. Altering the chemotherapy drugs used and the timing of treatment substantially improved survival.

Cancer Currents: An NCI Cancer Research Blog